Vivo Capital IX LLC 13D and 13G filings for Larimar Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 5:27 pm Sale | 2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | Vivo Capital IX LLC | 326,888 1.800% | -326,891 (-50.00%) | Filing |
| 2020-06-11 5:07 pm Purchase | 2020-06-01 | 13G | Larimar Therapeutics, Inc. LRMR | Vivo Capital IX LLC | 653,779 4.300% | 653,779 (New Position) | Filing |